Institutions / TCG Crossover Management, LLC / Holdings
Back to TCG Crossover Management, LLC

TCG Crossover Management, LLC

All holdings · as of Dec 31, 2025

43 positions

CompanyClassValue ↓Shares% of portfolio
ABIVAX SA AMERICAN DEPOSITARY SHARES—$959.03M7,111,59631.7%
Cogent Biosciences, Inc.—$208.44M5,868,1626.9%
CG Oncology, Inc.—$152.39M3,670,2065.0%
Tango Therapeutics, Inc.—$113.07M12,762,0943.7%
CENTESSA PHARMACEUTICALS PLC—$107.20M4,286,4803.5%
Dyne Therapeutics, Inc.—$90.27M4,615,1443.0%
RAPT THERAPEUTICS INC—$87.47M2,582,4082.9%
Tyra Biosciences, Inc.—$76.19M2,898,1032.5%
Amylyx Pharmaceuticals, Inc.—$75.43M6,243,8122.5%
Savara IncSVRACommon Stock$74.54M12,362,2052.5%
Monte Rosa Therapeutics, Inc.—$72.48M4,622,1512.4%
Ocular Therapeutix, Inc—$69.69M5,740,2312.3%
Dianthus Therapeutics, Inc.—$69.09M1,676,6242.3%
EyePoint, Inc.—$65.27M3,572,3352.2%
Structure Therapeutics Inc.GPCRADR$64.05M920,8572.1%
SPYRE THERAPEUTICS, INC.—$62.26M1,900,5822.1%
Fulcrum Therapeutics, Inc.—$59.38M5,250,0002.0%
Liquidia CorpLQDACommon Stock$58.98M1,710,0842.0%
Biohaven Ltd.—$52.29M4,631,3171.7%
Immunovant, Inc.IMVTCommon Stock$42.22M1,660,9331.4%
Kodiak Sciences Inc.KODCommon Stock$40.42M1,445,5381.3%
ADC THERAPEUTICS SA—$40.21M11,390,1751.3%
LB PHARMACEUTICALS INCLBRXCommon Stock$38.84M1,745,0151.3%
Xencor Inc—$37.54M2,452,1381.2%
Revolution Medicines, Inc.—$34.77M436,4731.2%
AGIOS PHARMACEUTICALS, INC.—$32.17M1,181,8411.1%
ARVINAS, INC.—$31.62M2,666,2161.0%
Relay Therapeutics, Inc.—$27.24M3,220,1860.9%
Janux Therapeutics, Inc.—$24.70M1,789,6170.8%
Entrada Therapeutics, Inc.TRDACommon Stock$21.47M2,088,3920.7%
MBX Biosciences, Inc.MBXCommon Stock$20.50M650,0000.7%
Upstream Bio, Inc.UPBCommon Stock$20.20M743,8860.7%
Silence Therapeutics plcSLNADR$18.44M3,033,5600.6%
UROGEN PHARMA LTD—$16.80M717,3470.6%
Alector, Inc.—$15.60M10,000,0000.5%
Monopar Therapeutics Inc.MNPRCommon Stock$9.27M141,9150.3%
Avalo Therapeutics, Inc.—$8.77M483,0000.3%
Maze Therapeutics, Inc.—$7.20M173,8160.2%
Mirum Pharmaceuticals, Inc.—$4.90M62,0490.2%
LeonaBio, Inc.LONACommon Stock$3.35M464,3980.1%
Korro Bio, Inc.—$3.33M416,3010.1%
Ventyx Biosciences, Inc.—$2.86M316,1950.1%
Vistagen Therapeutics, Inc.VTGNCommon Stock$1.77M2,676,5800.1%
← PrevPage 1 of 1Next →